Arkolith/Insider Trading/TVRD/Form 4/A

Wirk Shaheen

DirectorTvardi Therapeutics, Inc. (TVRD) · full profile →Form 4/A · filed May 2, 2025
No Open-Market Flow
Open-Market Buys
$0
Open-Market Sells
$0
Net Open-Market Flow
$0
Transactions
2
2 non-derivative · 0 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Apr 15, 2025Grant(A)263K——263K
Apr 15, 2025Grant(A)176K——176K

Transaction Codes

A
Grant / award

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4/A filing (accession 0001415889-25-011857) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4/A XML